| ²é¿´: 1565 | »Ø¸´: 18 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß luren_1006 µÄ 32 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
[½»Á÷]
ÃÀ¹úÃ÷ÄáËÕ´ï´óѧPang lab³ÏÕв©ºó2-3ÈË£¨ÄÉÃ×£¬Ò©Îﻯѧ£¬ÃâÒߵȷ½Ïò£©£¬¾·Ñ³ä×ã
|
|||
|
Ã÷ÄáËÕ´ï´óѧҩѧԺHongbo PangʵÑéÊÒ³ÏÕв©ºó£¨ÄÉÃ×£¬Ò©Îﻯѧ£¬ÃâÒߵȷ½Ïò£© Ã÷ÄáËÕ´ï´óѧӵÓÐÈ«ÃÀǰÈýµÄҩѧԺÒÔ¼°Ò»ÖÚÊÀ½çÖøÃûµÄÀí¹¤¿ÆÏà¹ØÔºÏµ£¬ÒÔ¼°ÖøÃûµÄҽѧԺ¼°°©Ö¢Ñо¿ÖÐÐÄ¡£Dr. PangµÄʵÑéÊÒ¾ÍλÓÚн¨µÄMasonic Cancer Center building, »·¾³ÓÅÃÀ£¬ÉèÊ©ÏȽø¡£¿ÎÌâ×éÖÂÁ¦ÓÚÑз¢»ùÓÚ¶àëĵİÐÏòÒ©Î¼²²¡°ÐµãµÄɸѡ¼°Ñз¢£¬ÒÔ¼°ÄÉÃײÄÁÏÔËÊäµÄÓ¦Óü°»úÀíÑо¿¡£×Ô2018Äê³ÉÁ¢ÒÔÀ´£¬¿ÎÌâ×éÒÑ»ñµÃÃÀ¹ú¹úÁ¢ÎÀÉúÔº£¬Ã÷ÄáËÕ´ïÖÝÕþ¸®£¨Óë÷°ÂÕïËùºÏ×÷£©£¬ÒÔ¼°Ã÷´óµÄ¶àÏî»ù½ð£¬×ܼƳ¬¹ýÈý°ÙÍòÃÀÔª£¨direct cost£©¡£¿ÎÌâ×éÖÁ½ñÔÚÖªÃûÆÚ¿¯·¢±íÊ®ÓàÆªÂÛÎÄ£¬ÒÔ¼°¶àÏîרÀû¡£Dr.Pang»¹²ÎÓëÁ˶à¸ö³õ´´¹«Ë¾ÒÔת»¯Ñо¿³É¹û£¬²¢ÓÚ½ñÄê¸Õ¸Õ´´Á¢ÁËBoyan Therapeutics¡£ÏêÇéÇë¼ûʵÑéÊÒÍøÒ³£¬google scholar£¬ÒÔ¼°Lisata Therapeutics (NASDAQ: LSTA)¡£ ʵÑéÊÒÏּƻ®ÕÐÆ¸2-3λ²©Ê¿ºóÑо¿Ô±¡£¿ÎÌâ×éÏÖÔÚÓжà¸öÁìÓòµÄÏà¹Ø¿ÎÌ⣬ËùÒԶԺܶ౳¾°µÄÉêÇëÕß¶¼¸ÐÐËȤ£¬ÓÈÆäÊÇÓÐÒ©Îﻯѧ£¬ÄÉÃײÄÁÏ£¬¶¯ÎïÄ£Ðͽ¨Á¢£¬ÃâÒߵȾÑéµÄ»áÓÅÏÈ¿¼ÂÇ¡£Ã÷´ó¶Ô²©Ê¿ºóµÄ´ýÓöÓźñ£¬Ë«³ÇÒ²³£Äê±»ÆÀΪȫÃÀ×îÊʺϾÓסµÄ³ÇÊÐÖ®Ò»¡£ÓÐÒâÕßÇ뽫ÄãµÄ¼òÀúÒÔ¼°2-3·âÍÆ¼öÐÅ·¢µ½pang0051@umn.edu. Postdoctoral positions in University of Minnesota, Minneapolis 2-3 postdoctoral positions are immediately available in Dr. Hongbo Pang lab, Department of Pharmaceutics, College of Pharmacy, University of Minnesota (Minneapolis). UMN College of Pharmacy is ranked 3rd of pharmacy school nationwide according to U.S.News. Dr. Pang did his postdoc training with Dr. Erkki Ruoslahti, who is a world-renowned scientist in phage display/peptide therapeutics, and the Lasker Awardee in 2022. Pang lab harnesses interdisciplinary technologies to discover peptide-based targeting tools and novel biomarkers, develop novel peptide-based therapies for a variety of diseases, and explore novel cellular and physiological processes. Our group has been highly productive: since established in 2018, thirteen research articles have been published in high impact journals along with multiple patents. We also received multiple major NIH, State and University grants, which sums up to over $3 Million. Please refer to the lab website (https://www.pharmacy.umn.edu/bio/cop-experts/hongbo-pang) and google scholar for more information. Besides research, Dr. Pang is also active in biotech entrepreneurship. He is involved in Lisata Therapeutics (NASDAQ: LSTA) and the founder of Boyan Therapeutics. For these positions, we are looking for highly motivated and self-driven individuals to join in our research effort of developing peptide-based therapeutics against a wide variety of human diseases, especially acute and chronic inflammatory conditions. Another major direction is to explore the roles of extracellular vesicles in transport macromolecule drugs into solid tumors and other tissue types. The successful candidate will be also tasked/involved with projects ranging from peptide screening, disease modeling, peptide-drug/nanotechnology synthesis and therapeutic evaluation. Our current group is highly interdisciplinary with experts in material sciences, disease modeling, immunology, obesity, cell biology, and so on. Collaboration within the group as well as externally is highly encouraged. We are interested in applicants holding a PhD degree in a broad range of biomedical or material science fields. Candidates with experience in nanotechnology or medicinal chemistry, disease modeling, immunology or molecular/cell biology are highly encouraged to apply. The candidates are also expected to have outstanding interpersonal and organizational skills, as well as excellent communication and writing skills. To apply, please send a cover letter describing your past research experience and future interest, your CV and 2-3 reference letters to pang0051@umn.edu. The position will remain open until filled. |
» ²ÂÄãϲ»¶
Êý¶þÓ¢¶þ348Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
»¯¹¤Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
0710ÉúÎïѧ336·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
292Çóµ÷¼Á
ÒѾÓÐ20È˻ظ´
288Çóµ÷¼Á Ò»Ö¾Ô¸¹þ¹¤´ó ²ÄÁÏÓ뻯¹¤
ÒѾÓÐ38È˻ظ´
348·Ö»·¾³¹¤³Ì¡¤µ÷¼Á
ÒѾÓÐ4È˻ظ´
±¾¿Æ985£¬×¨Òµ0812·Ö336Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏ295
ÒѾÓÐ5È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
2026ÄêÕã½Å©ÁÖ´óѧ԰ÒÕѧԺ˶ʿÕÐÊÕ£¬½ÓÊÜ˶ʿµ÷¼ÁѧÉú
+1/190
î÷Îý»¯ºÏÎï°ëµ¼Ìå²ÄÁÏÓëÆ÷¼þÍŶÓ[ÍÆ½é]
+3/184
ÒË´ºÑ§Ôº ҩѧÑо¿Éúµ÷¼Á52ÈË
+1/50
Ñо¿Éúµ÷¼ÁÕÐÉú£¨44Ãû£©
+1/44
2026ÄêºÓ±±´óѧÎÞ»ú»¯Ñ§×¨ÒµÕÐÊÕµ÷¼ÁÉú
+1/40
Î÷°²¹¤³Ì´óѧ²ÄÁÏѧԺÑî½Ü¿ÎÌâ×éÕÐÊÕ¿¼Ñе÷¼ÁÉú
+1/39
ÄÏͨ´óѧ¹ú¼Ò¼¶È˲ÅÍŶÓÕÐÊÕҩѧ¡¢ÎÀÉú¼ìÑ顢ҽѧ¼ìÑé¡¢»ù´¡Ò½Ñ§Ïà¹Ø·½Ïòµ÷¼ÁÑо¿Éú
+1/37
ÉϺ£¹¤³Ì¼¼Êõ´óѧÑÇÎȲÄÁÏ¿ÎÌâ×éÕÐÊÕ˶ʿÑо¿Éú
+2/36
UJNÎïÀíѧרҵµ÷¼Á
+1/18
¸£½¨Ê¦·¶´óѧÉúÃü¿ÆÑ§Ñ§Ôº071000ÉúÎïѧµ÷¼Á
+1/18
¡¾ÇáËÉ×¼Èë¡¿¡¾ÉúÎïÒ½Ò©¡¿2026Çൺ´óѧÕв©Ê¿Éú
+1/16
µç×ÓÐÅÏ¢ÊýÒ»Ó¢Ò»336·ÖÇóµ÷¼Á
+1/14
Ï𽺲ÝÖÖ×ÓÇóÖú
+1/12
¸£½¨Àí¹¤´óѧ²ÄÁÏѧԺÕÐÊÕ2026˶ʿÑо¿Éú
+1/8
ÈýÏ¿´óѧ ÕÐÊÕµ÷¼Á£¨Êýѧ¡¢ÎïÀíѧ¡¢Á¦Ñ§¡¢¹¤Ñ§£©
+1/7
¹þ¹¤³ÌÑĮ̀Ժ²Ä»¯×¨Òµ2026µ÷¼ÁÐÅÏ¢
+1/4
[µ÷¼ÁÐÅÏ¢] ËÕÖݿƼ¼´óѧ»¯Ñ§ÓëÉúÃü¿ÆÑ§Ñ§ÔºÕÐÉúµ÷¼Á£¨²»ÏÞרҵ£¬ÐèÒª¿¼Êýѧ£©
+1/3
²³º£´óѧ²ÄÁÏÕÐÊÕµ÷¼Á
+1/2
ºÓ±±´óѧ»¯Ñ§Óë²ÄÁÏ¿ÆÑ§Ñ§ÔºÉúÎïÓëҽҩר˶½ÓÊܵ÷¼ÁÉú
+1/2
ÃÀ¹úÌïÄÉÎ÷Àí¹¤ | È˹¤ÖÇÄÜ/»úÆ÷ÈË/×Ô¶¯¼ÝÊ»·½Ïò£¨È«½±£©
+1/1
chenhuanlong
½û³æ (ÎÄѧ̩¶·)
¡ï
luren_1006(½ð±Ò+1): лл²ÎÓë
luren_1006(½ð±Ò+1): лл²ÎÓë
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
3Â¥2023-08-03 22:49:52
9Â¥2023-08-05 00:31:21
10Â¥2023-08-05 02:45:49
·ÉµÄÖí
Ìú¸Ëľ³æ (ÎÄ̳¾«Ó¢)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ¹ó±ö: 0.265
- ½ð±Ò: 9534.7
- Ìû×Ó: 19560
- ÔÚÏß: 842.3Сʱ
- ³æºÅ: 1020793
18Â¥2023-08-10 17:37:02
¼òµ¥»Ø¸´
tzynew2Â¥
2023-08-03 21:22
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
o ·¢×ÔСľ³æAndroid¿Í»§¶Ë
clarktao4Â¥
2023-08-04 08:41
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
gter_wang5Â¥
2023-08-04 08:48
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
miaojiabing6Â¥
2023-08-04 08:58
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
kobe190127Â¥
2023-08-04 11:42
»Ø¸´
shenrenren8Â¥
2023-08-04 20:11
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
jiaoxg11Â¥
2023-08-05 10:39
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë





sct7312Â¥
2023-08-05 12:44
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
XG-WUST13Â¥
2023-08-06 14:52
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
up ·¢×ÔСľ³æIOS¿Í»§¶Ë
kecikeci14Â¥
2023-08-07 08:13
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
wgatssd15Â¥
2023-08-08 15:23
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
toppaper16Â¥
2023-08-08 16:03
»Ø¸´
lylgszy17Â¥
2023-08-09 22:17
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
y333wu19Â¥
2023-08-12 10:05
»Ø¸´
luren_1006(½ð±Ò+1): лл²ÎÓë
















»Ø¸´´ËÂ¥

